Cardiac Glycoside Ouabain Efficiently Targets Leukemic Stem Cell Apoptotic Machinery Independent of Cell Differentiation Status

Researchers established two study models to specifically determine the effects of cardiac glycosides on leukemic stem cells (LSC) death and differentiation—one allowed change in dynamics of LSCs and leukemic progenitor cells (LPCs), while another maintained their undifferentiated status.